Effect of AD128 to Treat Obstructive Sleep Apnea

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

July 19, 2021

Study Completion Date

July 19, 2021

Conditions

Sleep Apnea, Obstructive

Interventions

DRUG

AD128

Oral administration of two capsules before sleep for 7 days.

DRUG

Mannitol

Oral administration of two capsules before sleep for 7 days.

Trial Locations (1)

Centre Hospitalier Universitaire Vaudois, Lausanne